Results 51 to 60 of about 2,056 (145)
Graphical Abstract and Lay Summary The anion‐exchange membrane elution chromatography for the separation of empty and full AAVs is explored and optimized. The role played by important parameters like flowrate, gradient slope, membrane loading, and feed residence time is studied in detail.
Luca Ossi +4 more
wiley +1 more source
Background Advanced Treatment Medicinal Products (ATMPs) are innovative treatments aimed at severe diseases. However, patient access varies across European countries. The present research reviews the reimbursement status of the licensed ATMPs in England,
Paraskevi M. Georgiou +1 more
doaj +1 more source
Abstract BACKGROUND Adeno‐Associated Virus vectors are widely used in gene therapy due to their safety and efficacy. Despite the interest in their therapeutical application, AAV purification remains a significant challenge. Density gradient ultracentrifugation using cesium chloride, sucrose, or iodixanol gradients are common methods for AAV ...
Sabrina Leigheb +6 more
wiley +1 more source
Nuevo horizonte en el tratamiento de la Distrofia Hereditaria de la Retina.Terapia génica: Luxturna
Aparicio Merinero, Carlos; director de proyecto: Tinoco Pastor, María Pilar2021-2022Grado en FarmaciaFacultad de Ciencias de la ...
Aparicio Merinero, Carlos
core +1 more source
ABSTRACT Purpose To explore the inherited retinal diseases (IRD) communities' attitudes and perspective toward emerging therapies—specifically gene therapy, cell therapy, and retinal prostheses—following a community education event. Methods At an in‐person half‐day IRD community education event, subject‐matter experts presented the scientific ...
Eden G. Robertson +4 more
wiley +1 more source
ABSTRACT Adeno‐associated viral (AAV) vectors for gene therapy are becoming integral to modern medicine, providing therapeutic options for diseases once deemed incurable. Currently, viral vector purification is a critical bottleneck in the gene therapy industry, impacting product efficacy and safety as well as accessibility and cost to patients ...
Kelvin P. Idanwekhai +9 more
wiley +1 more source
Review of gene therapies for age-related macular degeneration [PDF]
Gene therapies aim to deliver a therapeutic payload to specified tissues with underlying protein deficiency. Since the 1990s, gene therapies have been explored as potential treatments for chronic conditions requiring lifetime care and medical management.
Thomas, Mathew J +15 more
core +1 more source
Helper and ionizable lipids play a crucial role in determining ApoE binding and subsequent liver tropism and LDLR‐mediated uptake. Ionizable lipids primarily govern the LDLR‐independent uptake pathway. This complementary interplay between lipid components ultimately governs LNP delivery performance and therapeutic efficacy in the liver.
Ashish Sarode +16 more
wiley +1 more source
Terapia gênica in vivo e ex vivo: análise das tecnologias aplicadas em medicamentos aprovados pela Anvisa [PDF]
A terapia gênica, conceituada em 1972 por Theodore Friedmann e Richard Roblin, é um campo emergente que envolve técnicas de substituição, melhoria ou remodelação de genes para corrigir defeitos genéticos. A primeira aplicação bem-sucedida ocorreu em 1990,
Costa, André Lima de Oliveira +2 more
core +1 more source
Gene therapy for retinal diseases: From genetics to treatment
The gene therapy approach for retinal disorders has been considered largely over the last decade owing to the favorable outcomes of the US Food and Drug Administration-approved commercial gene therapy, Luxturna.
Ashish Khaparde +5 more
doaj +1 more source

